Pharmarise Holdings Valuation

Q: What is the Fair Price of 2796 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

2796 (¥616) is trading below our estimate of [[fair value]] (¥3468.91)

Is 2796 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2796 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2796 (¥616) is trading below our estimate of fair value (¥3468.91)

Significantly Below Fair Value: 2796 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2796?

Key metric: As 2796 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 2796. This is calculated by dividing 2796's market cap by their current revenue.
What is 2796's PS Ratio?
PS Ratio	0.1x
Sales	JP¥56.23b
Market Cap	JP¥6.93b

2796 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	7.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 2796's PS Ratio compare to its peers?

The above table shows the PS ratio for 2796 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.1x
3353 Medical Ikkou GroupLtd	0.2x	n/a	JP¥7.7b
3544 Satudora HoldingsLtd	0.1x	n/a	JP¥11.0b
4350 Medical System Network	0.1x	n/a	JP¥12.0b
9776 Sapporo Clinical Laboratory	0.2x	n/a	JP¥3.0b
2796 Pharmarise Holdings	0.1x	n/a	JP¥6.9b

Price-To-Sales vs Peers: 2796 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.1x).

Price to Sales Ratio vs Industry

How does 2796's PS Ratio compare vs other companies in the JP Consumer Retailing Industry?

11 Companies	Price / Sales	Estimated Growth	Market Cap
7451 Mitsubishi Shokuhin	0.1x	3.5%	US$1.35b
8228 MARUICHILtd	0.09x	n/a	US$155.53m
7675 Central Forest Group	0.06x	n/a	US$134.72m
8041 OUG Holdings	0.04x	n/a	US$88.89m

11 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 2796 is good value based on its Price-To-Sales Ratio (0.1x) compared to the JP Consumer Retailing industry average (0.2x).

Price to Sales Ratio vs Fair Ratio

What is 2796's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2796 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 2796's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.